Vaccines hold key to cutting malnutrition, GAVI CEO says

The GAVI Alliance CEO has warned that the role immunization has to play in breaking the infectious disease-malnutrition cycle is being overlooked. While evidence vaccines prevent chronic effects of malnutrition is becoming more prevalent, few programs to eradicate hunger factor in immunization. The health sector, not agriculture, holds the key, the CEO said. Op-ed

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.